Inactivation of Newcastle disease virus by beta-propiolactone.
D046508:Culture Techniques; D006389:Hemagglutinins, Viral; D006460:Hemolysin Proteins / Q000096:biosynthesis; D007783:Lactones / Q000494:pharmacology*; D009439:Neuraminidase / Q000096:biosynthesis; D009522:Newcastle disease virus / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D011420:Propiolactone / Q000494:pharmacology*; D012367:RNA, Viral / Q000378:metabolism; D012324:RNA-Dependent RNA Polymerase / Q000378:metabolism; D014158:Transcription, Genetic / Q000187:drug effects; D014764:Viral Proteins / Q000096:biosynthesis
D006389:Hemagglutinins, Viral; D006460:Hemolysin Proteins; D007783:Lactones; D012367:RNA, Viral; D014764:Viral Proteins; D011420:Propiolactone; D012324:RNA-Dependent RNA Polymerase; D009439:Neuraminidase